Illumina, Inc. (NDAQ:ILMN) was upgraded by investment analysts at Leerink Swann from a “mkt perform” rating to an “outperform” rating in a report issued on Monday, StockTargetPrices.com reports.

Shares of Illumina (NDAQ:ILMN) traded up 2.20% during mid-day trading on Monday, hitting $163.95. 892,649 shares of the company traded hands. The stock has a market capitalization of $23.99 billion and a price-to-earnings ratio of 53.40. Illumina has a one year low of $119.37 and a one year high of $186.88. The firm has a 50-day moving average of $163.67 and a 200-day moving average of $152.69.

Your IP Address:

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Stock Target Prices

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.